cours de bourse
14/08/2009 - 11:07:23|49.66 EUR 0.42 %
STALLERGENES S.A. (Euronext Paris), a global healthcare company...
Antony, France; 23 October 2014 – 6.00pm CET
Q3 2014 sales...
Stallergenes is a global pharmaceutical company with leading innovation, provider of allergy solutions all around the world.
Stallergenes’ comprehensive approach to allergic diseases includes a complete portfolio combining diagnosis products and treatments and a new generation of allergen immunotherapy treatments.